Overview

Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic

Status:
Unknown status
Trial end date:
2012-10-01
Target enrollment:
0
Participant gender:
All
Summary
During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and hospitalization.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Meir Medical Center
Treatments:
Budesonide
Budesonide, Formoterol Fumarate Drug Combination
Formoterol Fumarate
Criteria
Inclusion Criteria:

age : 6-18 years suffering from asthma asthma exacerbation during 1/9/2009-15/10/2009

-

Exclusion Criteria:

any chronic condition that can involve respiratory tract (other than asthma) treated as
prevention with ICS or montelukast from July 2010 Treated with oral steroids during the
August 2010 asthma exacerbation one week prior study inclusion